BlackRock Institutional Trust’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

BlackRock Institutional Trust’s Portfolio AVEO Stock Details AVEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$1.05M	Hold	194,598	–	–	﹤0.01%	3281
2016 Q3	$1.73M	Hold	194,598	–	–	﹤0.01%	3105
2016 Q2	$1.87M	Hold	194,598	–	–	﹤0.01%	3065
2016 Q1	$1.79M	Hold	194,598	–	–	﹤0.01%	3082
2015 Q4	$2.45M	Hold	194,598	–	–	﹤0.01%	3036
2015 Q3	$2.35M	Sell	194,598 -32,481	-14%	-$469K	﹤0.01%	3061
2015 Q2	$3.95M	Buy	227,079 +936	+0.4%	+$16.8K	﹤0.01%	2849
2015 Q1	$3.28M	Buy	226,143 +3,156	+1%	+$34.5K	﹤0.01%	2911
2014 Q4	$1.87M	Hold	222,987	–	–	﹤0.01%	3134
2014 Q3	$2.48M	Buy	222,987 +6,473	+3%	+$82.3K	﹤0.01%	2981
2014 Q2	$3.96M	Sell	216,514 -34,962	-14%	-$455K	﹤0.01%	2888
2014 Q1	$3.76M	Sell	251,476 -122,724	-33%	-$2.2M	﹤0.01%	2891
2013 Q4	$6.85M	Buy	374,200 +161,125	+76%	+$3.23M	﹤0.01%	2639
2013 Q3	$4.39M	Buy	213,075 +9,099	+4%	+$208K	﹤0.01%	2788
2013 Q2	$5.1M	Buy	+203,976	New	+$8.72M	﹤0.01%	2691

Other funds holding AVEO

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

DVC

Deer VI & Co Larchmont, New York $2.23M AUM 9.32% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

BlackRock Institutional Trust's AVEO Position: Q4 2016 in Review

BlackRock Institutional Trust held its AVEO Pharmaceuticals, Inc. (AVEO) position steady in Q4 2016 at 194,598 shares worth $1.05M. The position accounts for ﹤0.01% of the portfolio, ranked #3281.

BlackRock Institutional Trust first reported a position in AVEO in Q2 2013 and has held it in 15 quarters since. The position peaked at $6.85M in Q4 2013. 44 funds tracked by Wall St. Rank hold AVEO as of Q4 2016.

BlackRock Institutional Trust held 194,598 shares of AVEO Pharmaceuticals, Inc. worth $1.05M as of Q4 2016.
BlackRock Institutional Trust left its AVEO Pharmaceuticals, Inc. share count unchanged in Q4 2016.
AVEO Pharmaceuticals, Inc. made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #3281 holding.
BlackRock Institutional Trust first reported a position in AVEO Pharmaceuticals, Inc. in Q2 2013 and has held it in 15 quarters since.
BlackRock Institutional Trust's AVEO Pharmaceuticals, Inc. position peaked at $6.85M in Q4 2013.
44 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.